Home WebinarsTPD Webinar-Global

TPD Webinar-Global

WEBINAR

Our upcoming webinar titled "Innovative Approaches for Targeted Protein Degradation" will showcase our comprehensive portfolio of products, ranging from complete to partial PROTACs, E3 engagers, and individual linkers, which support researchers in all stages of PROTAC^® studies. Assessing the efficacy of PROTAC^® molecules requires visualizing and verifying their activities, especially the involved protein-protein interactions (PPIs). The Duolink^® Proximity Ligation Assay (PLA) is an effective tool for observing and studying these PPIs, and we will discuss its utility in this field. Additionally, we will present case studies demonstrating how cell culture can be leveraged to advance targeted protein degradation research.

What you will learn in this webinar:

The latest developments in PROTAC^® research, including portfolio of products that support researchers in all stages of PROTAC^® studies.
How to evaluate the efficacy of PROTACs by visualizing and verifying their protein-protein interactions (PPIs) using the Duolink^® Proximity Ligation Assay (PLA).
Examples of how cell culture can be utilized in the field of targeted protein degradation.

Speakers

Angelo Lanzilotto

Merck

Technology Manager Chemistry Innovation

Angelo Lanzilotto obtained his PhD in Chemistry from the University of Basel in 2017 and has since then worked in therapeutic discovery of biologics and medicinal chemistry. He joined Merck in 2021 as a Scientific Specialist for Chemistry and later moved to the Technology Management team, where he focuses on the introduction of new products, from reagents to instrumentation, including software and services.

Carmela Foti

Merck

Technology Manager

Carmela received her Ph.D. in Biomedical Technologies from the University of Udine, in 2009. Her research interests encompass apoptosis, autophagy, and new drug screening. Throughout her career, she has published numerous articles in peer-reviewed journals, contributing to her field of expertise. Carmela has held various roles at Merck and currently serves as a Technology Manager in protein analysis supporting the introduction of new technologies and fosters scientific progress.

Cornelia Roessler

Merck

Technology Manager

Following her doctoral thesis at the Institute of Biochemistry in Frankfurt, Dr. Cornelia Roessler started her professional experience at Chemicon International. After several acquisitions and now more than 20 years of experience in the Cell Culture area she is working as a Technology Manager at Merck handling the entire Cell Culture portfolio together with a colleague for Europe.